Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone sustained-release tablets plus oxycodone capsules titration for moderate to severe cancer pain
ChiCTR1900028175Phase 4Not yet recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxycodone in cancer pain, sponsored by Anhui Provincial Tumor Hospital. Primary endpoint: Pain relief rate at 24 hours. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR1900028175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028175.